Newron agrees Parkinson’s drug deal with Zambon
http://www.reuters.com/article/2012/04/05/us-newron-idUSBRE83406D20120405?feedType=RSS&feedName=healthNews&ca=moto (Reuters) – Italian drug maker Newron has signed a strategic collaboration and licensing deal for its Parkinson’s disease drug safinamide with Italian drugs and chemicals maker Zambon which involves Zambon taking a 9.1 percent stake in Newron. Newron said…
